HLS Therapeutics Inc (74D) Q2 2025 Earnings Report
DE:74D Q2 2025 EPS Results
- Actual EPS
- -EUR 0.08
- Consensus EPS
- -EUR 0.07
- Beat/Miss
- Missed by -EUR 0.01
- One Year Ago EPS
- -EUR 0.16
DE:74D Q2 2025 Revenue Results
- Actual Revenue
- EUR 12.57M
- Expected Revenue
- EUR 12.98M
- Beat/Miss
- Missed by -EUR 410.47K
- YoY Revenue Growth
- -1.20%
Earnings Announcement Details
- Quarter
- Q2 2025
- Date
- 08/14/2025
- Time
- Before Open
- Conference Call
- Thursday, August 14, 2025
DE:74D Upcoming Earnings
HLS Therapeutics Inc's next earnings date is estimated for November 12, 2026, based on past reporting schedules.
Q2 2025 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2025 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2025 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:74D Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 12, 2026 | 2026 (Q3) | -0.06- | -0.11 | ― | ― |
| Aug 12, 2026 | 2026 (Q2) | -0.07-0.03 | -0.08 | 66.67% (+0.05) | |
| Mar 12, 2026 | 2025 (Q4) | -0.03-0.04 | -0.09 | 60.00% (+0.05) | |
| Nov 13, 2025 | 2025 (Q3) | -0.06-0.11 | -0.13 | 20.00% (+0.03) | |
| Nov 13, 2025 | 2026 (Q1) | -0.11-0.06 | -0.13 | 50.00% (+0.06) | |
| Aug 14, 2025 | 2025 (Q2) | -0.07-0.08 | -0.16 | 50.00% (+0.08) | |
| May 08, 2025 | 2025 (Q1) | -0.11-0.13 | -0.17 | 26.32% (+0.04) | |
| Mar 13, 2025 | 2024 (Q4) | -0.08-0.09 | -0.15 | 41.18% (+0.06) | |
| Nov 07, 2024 | 2024 (Q3) | -0.11-0.13 | -0.19 | 28.57% (+0.05) | |
| Aug 08, 2024 | 2024 (Q2) | -0.14-0.16 | -0.26 | 37.93% (+0.10) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
